- Home
- EVAX vs JCSE Comparison
EVAX vs JCSE Comparison
Compare EVAX & JCSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVAX
- JCSE
- Stock Information
- Founded
- EVAX 2008
- JCSE 1999
- Country
- EVAX Denmark
- JCSE Singapore
- Employees
- EVAX N/A
- JCSE N/A
- Industry
- EVAX Biotechnology: Biological Products (No Diagnostic Substances)
- JCSE Miscellaneous manufacturing industries
- Sector
- EVAX Health Care
- JCSE Consumer Discretionary
- Exchange
- EVAX Nasdaq
- JCSE Nasdaq
- Market Cap
- EVAX 8.7M
- JCSE 7.6M
- IPO Year
- EVAX 2021
- JCSE 2022
- Fundamental
- Price
- EVAX $2.41
- JCSE $1.45
- Analyst Decision
- EVAX Strong Buy
- JCSE
- Analyst Count
- EVAX 2
- JCSE 0
- Target Price
- EVAX $11.00
- JCSE N/A
- AVG Volume (30 Days)
- EVAX 250.1K
- JCSE 34.8K
- Earning Date
- EVAX 10-31-2024
- JCSE 10-30-2024
- Dividend Yield
- EVAX N/A
- JCSE 12.16%
- EPS Growth
- EVAX N/A
- JCSE N/A
- EPS
- EVAX N/A
- JCSE 0.12
- Revenue
- EVAX $3,295,000.00
- JCSE $14,723,999.00
- Revenue This Year
- EVAX $4,845.21
- JCSE N/A
- Revenue Next Year
- EVAX $30.30
- JCSE N/A
- P/E Ratio
- EVAX N/A
- JCSE $12.07
- Revenue Growth
- EVAX N/A
- JCSE N/A
- 52 Week Low
- EVAX $2.38
- JCSE $0.60
- 52 Week High
- EVAX $68.05
- JCSE $2.39
- Technical
- Relative Strength Index (RSI)
- EVAX 23.50
- JCSE 52.83
- Support Level
- EVAX $2.38
- JCSE $1.37
- Resistance Level
- EVAX $3.90
- JCSE $1.58
- Average True Range (ATR)
- EVAX 0.51
- JCSE 0.09
- MACD
- EVAX -0.05
- JCSE 0.01
- Stochastic Oscillator
- EVAX 2.72
- JCSE 61.26
About EVAX Evaxion Biotech A/S
Evaxion Biotech AS is a clinical-stage biotech company that aspires to the exploration of artificial intelligence, or AI, to develop immunotherapies with improved efficacy when compared to currently marketed products for patients with unmet medical needs. Its pipeline programs are derived from its proprietary AI platforms, PIONEER, EDEN, RAVEN, and ObsERV. The company is utilizing these AI platforms to build a drug development pipeline. Its product candidates are; EVX-01 and EVX-02, for the treatment of various cancers, and the third candidate is cancer immunotherapy, EVX-03, for the treatment of various cancers including non-small-cell-lung-cancer, or NSCLC, is in pre-clinical development.
About JCSE JE Cleantech Holdings Limited
JE Cleantech Holdings Ltd is engaged in the manufacturing and selling of cleaning systems and other equipment that can be categorized into four different categories, namely aqueous washing systems, plating and cleaning systems, train cleaning systems, and other equipment, such as filtration units. The product lives of its cleaning systems and other equipment range from two to ten years. The company is also into designing, developing, and manufacturing other cleaning systems for various industrial end-use applications using its R&D and engineering capabilities. It derives a majority of its revenue from Singapore.